Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Ibuprofen Versus Placebo in Management of Patent Ductus Arteriosus in Preterm Infants: A Double Blind, Randomized Control Trial

NCT05493540 is registered in ClinicalTrials.gov with Nada Youssef as lead sponsor.

NCT NCT05493540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05493540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Ibuprofen Versus Placebo in Management of Patent Ductus Arteriosus in Preterm Infants: A Double Blind, Randomized Control Trial
Lead sponsor
Nada Youssef
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2021
Completion date
September 1, 2022
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus after premature birth, patent ductus arteriosus conservative management